UPDATE: SVB Leerink On Universal Health Market Perform Initiation: Firm Warns On 'Under-Appreciated Headwinds From Medical Supplemental Programs' Coupled With Underwhelming Behavioral Growth Driving Downside Risks; Sees 0-1% Organic EBITDA Growth